| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 04/18/2002 | US20020045756 Preparation of camptothecin and of its derivatives |
| 04/18/2002 | US20020045750 Asymetric hemisynthesis of harringtonines and their analogs, that are alkaloids used in chemotherapy. |
| 04/18/2002 | US20020045653 C4 side-chain modified nodulisporic acid analogs |
| 04/18/2002 | US20020045638 Method of treating estrogen receptor positive carcinoma |
| 04/18/2002 | US20020045609 Epothilone derivatives and methods for making and using the same |
| 04/18/2002 | US20020045598 Nonacyclic nodulisporic acid derivatives |
| 04/18/2002 | US20020044899 Controlled, super-fine grinding so particles react completely during leaching; extraction of copper from copper sulfide ores and concentrates |
| 04/18/2002 | CA2427499A1 Substituted indoles, pharmaceutical compositions containing such indoles and their use as ppar-.gamma. binding agents |
| 04/18/2002 | CA2425632A1 Agents for the treatment of viral infections |
| 04/18/2002 | CA2394084A1 Inhibitors of protein kinases |
| 04/17/2002 | EP1197485A1 Cyclobuten-dione derivatives for use in the treatment of artherosclerosis |
| 04/17/2002 | EP1196410A1 Respiratory syncytial virus replication inhibitors |
| 04/17/2002 | EP1196398A1 Bridged fluorescent dyes, their preparation and their use in assays |
| 04/17/2002 | EP1196397A1 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 04/17/2002 | EP1042322B1 Kv2.1 ANTAGONISTS |
| 04/17/2002 | EP1005464B1 Photochromic naphthopyrans |
| 04/17/2002 | EP0804186B1 Indole diterpene alkaloid compounds |
| 04/17/2002 | CN1345321A Optically pure camptothecin analogues |
| 04/17/2002 | CN1345320A Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands |
| 04/17/2002 | CN1345319A Triazole compounds with dopamine-D3-receptor affinity |
| 04/17/2002 | CN1345318A Triazole compounds with dopamine -D3-receptor affinity |
| 04/17/2002 | CN1082814C Nodulisporic acid derivatives |
| 04/16/2002 | US6372907 Labelled rhodamine dye-polypeptide conjugate, or salt thereof, comprising rhodamine-type parent xanthene ring substituted at xanthene c-9 carbon with substituted phenyl ring |
| 04/16/2002 | US6372906 Reacting camptothecin or homocamptothecin with silyl radical precursor under conditions to generate silyl radical |
| 04/16/2002 | US6372758 Sulfamato hydroxamic acid metalloprotease inhibitor |
| 04/16/2002 | CA2260413C Terpenoid lactone compounds and their production process |
| 04/16/2002 | CA2076948C Isatineoxime derivatives, their preparation and use |
| 04/11/2002 | WO2002028850A1 Promoters for the proliferation and differentiation of stem cells and/or neuron precursor cells |
| 04/11/2002 | WO2002028837A1 Metabotropic glutamate receptor antagonists |
| 04/11/2002 | WO2002028820A1 Nitroso diphenylamine derivatives |
| 04/11/2002 | US20020042427 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors |
| 04/11/2002 | US20020042415 Dipeptide derivatives |
| 04/11/2002 | US20020042406 Ring opening metathesis of alkenes |
| 04/11/2002 | CA2424870A1 Agents for promoting the proliferation or differentiation of stem cells or neural progenitor cells |
| 04/11/2002 | CA2424684A1 Nitroso diphenylamine derivatives |
| 04/11/2002 | CA2421782A1 Quinoline and quinolinone derivatives as metabotropic glutamate receptor antagonists |
| 04/10/2002 | EP0918774B9 Androgen receptor modulator compounds and methods |
| 04/10/2002 | EP0813535B1 Hexacyclic camptothecin analogues, and process for preparing them |
| 04/10/2002 | EP0734387B1 Hiv protease inhibitors |
| 04/10/2002 | EP0712402B1 Hydroisoquinoline derivatives |
| 04/10/2002 | CN1344270A Functionalized heterocycles as chemokine receptor modulators |
| 04/10/2002 | CN1344264A Tetrahydropyran derivatives and their use as therapeutic agents |
| 04/10/2002 | CN1343669A Process for extracting tetrodosin with high output rate |
| 04/10/2002 | CN1082543C Polycyclic antiparasitic agents, process and strain for their prepn. and use |
| 04/09/2002 | US6369227 Thrombin or factor Xa inhibitors |
| 04/09/2002 | US6369224 Spiroazabicyclic heterocyclic amine borane complexes; psychological, nervous system and brain disorders; anxiolytic agents, antidepressants, analgesics; alzheimer*s and parkinson*s disease; smoking cessationa |
| 04/09/2002 | US6369086 Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors |
| 04/09/2002 | US6369072 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| 04/09/2002 | US6369053 2-Aminoquinolinecarboxamides: neurokinin receptor ligands |
| 04/09/2002 | CA2228595C Novel water-soluble c-ring analogues of 20 (s)-camptothecin |
| 04/09/2002 | CA2142560C Acronycin analogues; process for preparing the same and pharmaceutical compositions containing them |
| 04/04/2002 | WO2002027010A1 Xanthone compound |
| 04/04/2002 | WO2002026890A1 3-spiro-cyanin fluorochromes and their use in bioassays |
| 04/04/2002 | WO2002026744A1 Mpc1001 derivatives |
| 04/04/2002 | WO2002026743A1 Novel pyridazine compounds for the treatment of diabetes |
| 04/04/2002 | WO2002026734A1 PIPERAZIN-2-ONE AMIDES AS INHIBITORS OF FACTOR Xa |
| 04/04/2002 | WO2002026730A2 Fluorinated quinolones as antimitotic and antitumor agents |
| 04/04/2002 | WO2001090079A3 Novel carbamates and carbamides, production and use thereof as endothelin receptor antagonists |
| 04/04/2002 | WO2001089451A3 Protease inhibitors |
| 04/04/2002 | DE10046215A1 Fluorochrome und deren Verwendung Fluorochromes and their use |
| 04/04/2002 | CA2423482A1 Fluorinated quinolones as antimitotic and antitumor agents |
| 04/04/2002 | CA2422873A1 Piperazin-2-one amides as inhibitors of factor xa |
| 04/03/2002 | EP1192165A2 Substituted heterocycle fused gamma-carbolines |
| 04/03/2002 | EP1192164A1 Thieno- and furopyrimidine derivatives as a2a-receptor antagonists |
| 04/03/2002 | EP1192161A2 Chromeno[4,3,2-de]isoquinolines as potent dopamine receptor ligands |
| 04/03/2002 | EP1053472A4 Energy transfer dyes |
| 04/03/2002 | CN1343209A Camptothecin derivatives having antitumor activity |
| 04/03/2002 | CN1343208A Pyridopyranoazepine derivatives, preparation and therapeutic use |
| 04/03/2002 | CN1342774A Antineoplastic antibiotic prepared by microbe fermentation |
| 04/02/2002 | US6365759 Intermediate compounds for preparing macrocylcic analogs |
| 04/02/2002 | US6365749 Process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
| 04/02/2002 | US6365605 Substituted hydrochromenopyrroles |
| 04/02/2002 | US6365594 As opioid agonists and antagonists and are useful as i.a. analgesics |
| 04/02/2002 | US6365587 Substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 04/02/2002 | US6365586 Compounds, their preparation and use |
| 04/02/2002 | US6365301 Delocalized nitrogen, oxygen, sulfur or phoshorous onium cation; bis-fluorosulfonimidide anion or bis-difluorophos-phonylamidide anion |
| 04/02/2002 | CA2066780C 10,11-methylenedioxy-20(rs)-camptothecin and 10,11-methylenedioxy-20(s)-camptothecin analogs |
| 03/28/2002 | WO2002025648A1 Optical data carrier containing a phthalocyanine colouring agent as a light absorbing compound in the information layer |
| 03/28/2002 | WO2002025205A1 Optical data storage device containing a co-phthalocyanin complex in the optically writable information layer |
| 03/28/2002 | WO2002024703A1 Bicyclic heteroaromatic compounds |
| 03/28/2002 | WO2002024702A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 03/28/2002 | WO2002024655A1 Isoquinolinone potassium channel inhibitors |
| 03/28/2002 | WO2002024653A1 Compounds and methods for modulation of estrogen receptors |
| 03/28/2002 | WO2002024650A2 Pyridinone and pyridinethione derivatives having hiv inhibiting properties |
| 03/28/2002 | WO2002024641A1 Tricyclic indole compounds having affinity for serotonin receptor |
| 03/28/2002 | WO2002024636A2 N-acylsulfonamide apoptosis promoters |
| 03/28/2002 | WO2001092265A3 Indolinospiropyran compounds and methods for their manufacture |
| 03/28/2002 | US20020038029 Method for the synthesis of quinoline derivatives |
| 03/28/2002 | US20020037254 Conjugate for differentiating between healthy and unhealthy tissue |
| 03/28/2002 | CA2423106A1 Compounds and methods for modulation of estrogen receptors |
| 03/28/2002 | CA2423071A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 03/27/2002 | EP1189905A1 Substituted heterocycle fused gamma-carbolines |
| 03/27/2002 | EP1189904A1 Substituted heterocycle fused gamma-carbolines |
| 03/27/2002 | EP1189612A1 Vla-4 inhibitor compounds |
| 03/27/2002 | EP0790996B1 Pyridazinoquinoline compounds |
| 03/26/2002 | US6362181 Bactericides; enzyme inhibitors; antitumor agents |
| 03/26/2002 | US6362178 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 03/21/2002 | WO2002022618A1 Method for preparing camptothecin and its derivatives |
| 03/21/2002 | WO2002022617A1 A method of extracting tetrodotoxin |
| 03/21/2002 | WO2002022608A1 Pyrazole compounds useful as protein kinase inhibitors |